ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,656.83
-1.84%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.457
0.20%
Brent Oil
83.10
-1.47%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) ニュース

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VNDA
日付受信時刻ニュースソース見出しコード企業名
2017/05/0206 : 45PR Newswire (US)Vanda Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/04/2720 : 06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/04/2720 : 02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/04/1405 : 45PR Newswire (US)Vanda Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 2, 2017NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/04/0106 : 03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/3006 : 40PR Newswire (US)Vanda and UCSF Announce License Agreement for CFTR Activators and InhibitorsNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/1406 : 23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/0706 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/0706 : 05PR Newswire (US)Vanda Pharmaceuticals Announces Participation at March 2017 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/0407 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/0407 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/0407 : 33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/03/0407 : 32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1806 : 05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1721 : 04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1706 : 41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1606 : 26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1606 : 01PR Newswire (US)Vanda Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1508 : 11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1507 : 52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/1423 : 02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/02/0707 : 37Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/2720 : 07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/2006 : 30PR Newswire (US)Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/1320 : 03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/1306 : 53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/0921 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/0921 : 00PR Newswire (US)Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2016 Revenue Results and 2017 Financial GuidanceNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/0607 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/01/0607 : 09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VNDA

最近閲覧した銘柄

CCOM
US30
US 30
CCOM
US100
US Tech 100
NYSE
MRK
Merck
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
NYSE
MCD
McDonalds
USOTC
BNPQY
BNP Paribas (QX)
USOTC
RHHBY
Roche (QX)
NYSE
CVX
Chevron
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
USOTC
ADDYY
Adidas (QX)
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有